1. FRI0301 A Phase I Pharmacokinetics TRIAL Comparing PF-06438179 (A Potential Biosimilar) and Infliximab in Healthy Volunteers (Reflections B537-01). (10th June 2014) Authors: Udata, C.; Hua, S.Y.; Yin, D.; Salts, S.; Meng, X.; Rehman, M.I. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0142 Immunogenicity Assessment of PF-06438179, A Potential Biosimilar to Infliximab, In Healthy Volunteers. (9th June 2015) Authors: Udata, C.; Yin, D.; Cai, C.-H.; Hua, S.Y.; Salts, S.; Rehman, M.I.; AL-Sabbagh, A.; McClellan, J.; Meng, X. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗